Cargando…

Application of Mass Spectrometry Technology to Early Diagnosis of Invasive Fungal Infections

We recently developed a mass spectrometry (MS) procedure based on the detection of a serum disaccharide (MS-DS) in patients with invasive candidiasis (IC). Here, we compare the performance of MS-DS for the diagnosis of IC, invasive aspergillosis (IA), and mucormycosis (MM) with those of commercially...

Descripción completa

Detalles Bibliográficos
Autores principales: Mery, Alexandre, Sendid, Boualem, François, Nadine, Cornu, Marjorie, Poissy, Julien, Guerardel, Yann, Poulain, Daniel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5078558/
https://www.ncbi.nlm.nih.gov/pubmed/27605710
http://dx.doi.org/10.1128/JCM.01655-16
_version_ 1782462405145526272
author Mery, Alexandre
Sendid, Boualem
François, Nadine
Cornu, Marjorie
Poissy, Julien
Guerardel, Yann
Poulain, Daniel
author_facet Mery, Alexandre
Sendid, Boualem
François, Nadine
Cornu, Marjorie
Poissy, Julien
Guerardel, Yann
Poulain, Daniel
author_sort Mery, Alexandre
collection PubMed
description We recently developed a mass spectrometry (MS) procedure based on the detection of a serum disaccharide (MS-DS) in patients with invasive candidiasis (IC). Here, we compare the performance of MS-DS for the diagnosis of IC, invasive aspergillosis (IA), and mucormycosis (MM) with those of commercially available antigen detection tests. This retrospective study included 48 patients (23 IC patients [74 serum samples], 15 IA patients [40 serum samples], and 10 MM patients [15 serum samples]) and 49 appropriate controls (102 serum samples). MS-DS, mannan (Mnn), galactomannan (GM), and (1,3)-β-d-glucan (BDG) were detected by matrix-assisted laser desorption ionization–time of flight (MALDI-TOF) MS, Platelia, and Fungitell assays, respectively. For IC, the sensitivity and specificity of the MS-DS index, BDG detection, and Mnn detection were 62% and 84%, 82% and 60%, and 33% and 94% per serum sample and 83% and 69%, 96% and 31%, and 39% and 86% per patient, respectively. For IA, the corresponding values in comparison to BDG and GM detection were 83% and 81%, 62% and 95%, and 62% and 100% per serum sample and 93% and 76%, 87% and 90%, and 93% and 100% per patient, respectively. Nine of the 10 MM patients had a positive MS-DS result. MS-DS gave an early diagnosis in IC (73% positivity before blood culture), IA (positive before GM detection in six patients), and MM (positivity mainly preceded the date of diagnosis) patients. For IC, persisting MS-DS was associated with a poor prognosis. The different biomarkers were rarely detected simultaneously, suggesting different kinetics of release and clearance. For IA, MS-DS provided better complementation to GM monitoring than BDG monitoring. MS-DS detects panfungal molecules circulating during invasive fungal infections. The performance of MS-DS compared favorably with those of biological tests currently recommended for monitoring at-risk patients. Further validation of this test in multicenter studies is required.
format Online
Article
Text
id pubmed-5078558
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher American Society for Microbiology
record_format MEDLINE/PubMed
spelling pubmed-50785582016-11-11 Application of Mass Spectrometry Technology to Early Diagnosis of Invasive Fungal Infections Mery, Alexandre Sendid, Boualem François, Nadine Cornu, Marjorie Poissy, Julien Guerardel, Yann Poulain, Daniel J Clin Microbiol Mycology We recently developed a mass spectrometry (MS) procedure based on the detection of a serum disaccharide (MS-DS) in patients with invasive candidiasis (IC). Here, we compare the performance of MS-DS for the diagnosis of IC, invasive aspergillosis (IA), and mucormycosis (MM) with those of commercially available antigen detection tests. This retrospective study included 48 patients (23 IC patients [74 serum samples], 15 IA patients [40 serum samples], and 10 MM patients [15 serum samples]) and 49 appropriate controls (102 serum samples). MS-DS, mannan (Mnn), galactomannan (GM), and (1,3)-β-d-glucan (BDG) were detected by matrix-assisted laser desorption ionization–time of flight (MALDI-TOF) MS, Platelia, and Fungitell assays, respectively. For IC, the sensitivity and specificity of the MS-DS index, BDG detection, and Mnn detection were 62% and 84%, 82% and 60%, and 33% and 94% per serum sample and 83% and 69%, 96% and 31%, and 39% and 86% per patient, respectively. For IA, the corresponding values in comparison to BDG and GM detection were 83% and 81%, 62% and 95%, and 62% and 100% per serum sample and 93% and 76%, 87% and 90%, and 93% and 100% per patient, respectively. Nine of the 10 MM patients had a positive MS-DS result. MS-DS gave an early diagnosis in IC (73% positivity before blood culture), IA (positive before GM detection in six patients), and MM (positivity mainly preceded the date of diagnosis) patients. For IC, persisting MS-DS was associated with a poor prognosis. The different biomarkers were rarely detected simultaneously, suggesting different kinetics of release and clearance. For IA, MS-DS provided better complementation to GM monitoring than BDG monitoring. MS-DS detects panfungal molecules circulating during invasive fungal infections. The performance of MS-DS compared favorably with those of biological tests currently recommended for monitoring at-risk patients. Further validation of this test in multicenter studies is required. American Society for Microbiology 2016-10-24 2016-11 /pmc/articles/PMC5078558/ /pubmed/27605710 http://dx.doi.org/10.1128/JCM.01655-16 Text en Copyright © 2016 Mery et al. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license (http://creativecommons.org/licenses/by/4.0/) .
spellingShingle Mycology
Mery, Alexandre
Sendid, Boualem
François, Nadine
Cornu, Marjorie
Poissy, Julien
Guerardel, Yann
Poulain, Daniel
Application of Mass Spectrometry Technology to Early Diagnosis of Invasive Fungal Infections
title Application of Mass Spectrometry Technology to Early Diagnosis of Invasive Fungal Infections
title_full Application of Mass Spectrometry Technology to Early Diagnosis of Invasive Fungal Infections
title_fullStr Application of Mass Spectrometry Technology to Early Diagnosis of Invasive Fungal Infections
title_full_unstemmed Application of Mass Spectrometry Technology to Early Diagnosis of Invasive Fungal Infections
title_short Application of Mass Spectrometry Technology to Early Diagnosis of Invasive Fungal Infections
title_sort application of mass spectrometry technology to early diagnosis of invasive fungal infections
topic Mycology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5078558/
https://www.ncbi.nlm.nih.gov/pubmed/27605710
http://dx.doi.org/10.1128/JCM.01655-16
work_keys_str_mv AT meryalexandre applicationofmassspectrometrytechnologytoearlydiagnosisofinvasivefungalinfections
AT sendidboualem applicationofmassspectrometrytechnologytoearlydiagnosisofinvasivefungalinfections
AT francoisnadine applicationofmassspectrometrytechnologytoearlydiagnosisofinvasivefungalinfections
AT cornumarjorie applicationofmassspectrometrytechnologytoearlydiagnosisofinvasivefungalinfections
AT poissyjulien applicationofmassspectrometrytechnologytoearlydiagnosisofinvasivefungalinfections
AT guerardelyann applicationofmassspectrometrytechnologytoearlydiagnosisofinvasivefungalinfections
AT poulaindaniel applicationofmassspectrometrytechnologytoearlydiagnosisofinvasivefungalinfections